Literature DB >> 31205247

Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat?

Richard J Whitley1.   

Abstract

Congenital cytomegalovirus infections are among the most common of the newborn in the developed world. These infections are the most common cause of sensorineural hearing loss. Studies utilizing ganciclovir and valganciclovir demonstrate improved hearing and Bailey Developmental scores. Because of the ease of administration, valganciclovir is the recommended treatment of choice for 6 months. Therapy should be reserved for those babies with symptomatic disease; no data are available regarding the impact of treatment on those babies with asymptomatic disease.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31205247      PMCID： PMC6581200          DOI： 10.1097/INF.0000000000002325

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  59 in total

1.  Early clinical manifestations and intellectual outcome in children with symptomatic congenital cytomegalovirus infection.

Authors:  T J Conboy; R F Pass; S Stagno; C A Alford; G J Myers; W J Britt; F P McCollister; M N Summers; C E McFarland; T J Boll
Journal:  J Pediatr       Date:  1987-09       Impact factor: 4.406

2.  Mother-to-Child Transmission of Herpes Simplex Virus.

Authors:  Scott H James; Jeanne S Sheffield; David W Kimberlin
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09       Impact factor: 3.164

3.  Asymptomatic congenital cytomegalovirus infection. Audiologic, neuroradiologic, and neurodevelopmental abnormalities during the first year.

Authors:  W D Williamson; A K Percy; M D Yow; P Gerson; F I Catlin; M L Koppelman; S Thurber
Journal:  Am J Dis Child       Date:  1990-12

Review 4.  Congenital cytomegalovirus (CMV) infection and hearing deficit.

Authors:  Karen B Fowler; Suresh B Boppana
Journal:  J Clin Virol       Date:  2005-12-28       Impact factor: 3.168

Review 5.  Neonatal herpes simplex virus infection: epidemiology and treatment.

Authors:  Scott H James; David W Kimberlin
Journal:  Clin Perinatol       Date:  2014-12-04       Impact factor: 3.430

6.  Newborn screening for congenital cytomegalovirus: Options for hospital-based and public health programs.

Authors:  Scott D Grosse; Sheila Dollard; Danielle S Ross; Michael Cannon
Journal:  J Clin Virol       Date:  2009-09-26       Impact factor: 3.168

7.  The consequences of primary cytomegalovirus infection in pregnancy.

Authors:  P M Preece; J M Blount; J Glover; G M Fletcher; C S Peckham; P D Griffiths
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

8.  Cytomegalovirus infection in pregnancy: preliminary findings from a prospective study.

Authors:  C S Peckham; K S Chin; J C Coleman; K Henderson; R Hurley; P M Preece
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

9.  Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population.

Authors:  Marisa M Mussi-Pinhata; Aparecida Y Yamamoto; Rosângela M Moura Brito; Myriam de Lima Isaac; Patricia F de Carvalho e Oliveira; Suresh Boppana; William J Britt
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

10.  Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India.

Authors:  Lalit Dar; Sunil Kumar Pati; A Raj Kumar Patro; Ashok Kumar Deorari; Sanjay Rai; Shashi Kant; Shobha Broor; Karen B Fowler; William J Britt; Suresh B Boppana
Journal:  Pediatr Infect Dis J       Date:  2008-09       Impact factor: 2.129
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.